You are on page 1of 73

Photolabile Protecting Groups (PLPG): Synthetic and Biological Applications

Carmin Burrell October 15, 2008

First Examples: Cbz-glycine


O OH

O O

H N

H2, Pd/C or Li, NH3 or HBr

O H2N OH

O O

H N

O OH

h! (254 nm) Med. P Hg lamp 30 min, H2O 75%


H2N

O OH

Zweifel, G. S.; Nantz, M. H.; Modern Organic Synthesis: An Introduction; University Freeman: New York, 2007, 60. Barltrop, J. A.; Schoeld, P.; Tetrahedron Lett., 1962, 16, 697-699.

First Examples: o-Nitrobenzylesters


NO2

acetone h! (>280nm)

NO OH O NO2

O NO2 O2N H O

H Med. P Hg Lamp Pyrex Filter

h!
H O

O2N H O O H

(>280nm)

NO2 H O HO

NO H OH

NO OH O

Leighton, P. A.; Lucy, F. A., J. Chem. Phys., 1934, 2, 756-759. Barltrop, J.A.; Plant, P. J.; Schoeld, P.; Chem Comm, 1966, 22, 822-823.

First Examples: o-Nitrobenzylesters


NO2 H O R O

CCl4 h! (>280nm)
R'

O R'

O R

Med. P Hg lamp HO Pyrex Filter


R H Ph R' Ph Ph Time(hr) Yield 2.5 2.5 3.0 4.0 17 90 95 87

Ph C15H31 Ph CH2Ph

Barltrop, J.A.; Plant, P. J.; Schoeld, P.; Chem Comm, 1966, 22, 822-823.

Mechanism of Deprotection
O N O O O O N OH R O O R' O N O H O R O O N R' C R OH O O N O R HO R' O O

R' h!

R'

H R

H transfer

Barton, D. H. R.; Chow, Y. L.; Cox, A.; Kirby, G. W.; Tetrahedron Lett., 1962, 23, 1055-1057.

Excitation - Jablonski Diagram


S2 Internal conversion Vibrational relaxation S1 Excitation femto (10-15s) S0 Fluorescence nano (10-9s) pico 10-12s

Intersystem crossing T1 Phosphorescence !micro (10-6s)

Excitation promotes a HOMO electron to the LUMO Rearrangement occurs to cleave the PLPG
Laimgruber, S.; Schreier, W. J.; Schrader, T.; Koller, F.; Zinth, W.; Gilch, P.; Angew. Chem. Int. Ed. 2005, 44, 7901-7904.

Applications of PLPGs - Synthesis of (-)Diazonamide A


Me Me HO Me H N O HN O O O Cl O NH NH Me N N Cl

(-)-Diazonamide A

Snider, B. B.; Busuyek, M.V.; Tetrahedron, 2001, 57, 3301-3307. Li, J.; Jeong, S.; Esser, L.; Harran, P. G.; Angew. Chem. Int. Ed. 2001, 40, 4765-4769.

Applications of PLPGs - Synthesis of (-)Diazonamide A


Me Me Me HO Me H N HN N N Cl O O O O Cl O NH NH

(-)-Diazonamide A

Me HN CbzHN O

Me N O CN

Na HN

Me N O O CN

o-NO2C6H4CH2Br K2CO3, NaI, DMF 52% Br

CbzHN

Br O O Ph OH NO2

OH O Ph OH

Li, J.; Jeong, S.; Esser, L.; Harran, P. G.; Angew. Chem. Int. Ed. 2001, 40, 4765-4769.

Applications of PLPGs - Synthesis of (-)Diazonamide A


Me Me Me HO Me H N HN N N Cl O O O O Cl O NH NH

(-)-Diazonamide A

Me HN CbzHN O

Me N O CN CbzHN

Me HN O

Me N O O O

Cl3CCO2H
Br O O Ph OH NO2 Ph O O NO2 Br

Li, J.; Jeong, S.; Esser, L.; Harran, P. G.; Angew. Chem. Int. Ed. 2001, 40, 4765-4769.

Applications of PLPGs - Synthesis of (-)Diazonamide A


Me Me Me HO Me H N HN N N Cl O O O O Cl O NH NH

(-)-Diazonamide A

Me HN CbzHN O

Me N O O O N H

NHAlMe2 Me HN CbzHN O O Me N HN O

NH

O O Ph

1.3 eq, toluene/CH2Cl2 0C!RT Br 83% (2 steps)


NO2

Br O O Ph OH NO2

Li, J.; Jeong, S.; Esser, L.; Harran, P. G.; Angew. Chem. Int. Ed. 2001, 40, 4765-4769.

Applications of PLPGs - Synthesis of (-)Diazonamide A


Me Me Me HO Me H N HN N N Cl O O O O Cl O NH NH

(-)-Diazonamide A

NH Me HN CbzHN O O Me N HN O Me HN Me N O O HN O

NH

5 mol% nPr4NRuO4 1.5 eq NMO 4 MS, CH2Cl2 78%

CbzHN

Br O O Ph OH NO2

Br O O Ph O NO2

Li, J.; Jeong, S.; Esser, L.; Harran, P. G.; Angew. Chem. Int. Ed. 2001, 40, 4765-4769.

Applications of PLPGs - Synthesis of (-)Diazonamide A


Me Me Me HO Me H N HN N N Cl O O O O Cl O NH NH

(-)-Diazonamide A

NH Me HN CbzHN O O Me N HN O Me Me N O O HN O

NH

350nm, 3x10-2M degassed dioxane excess Ac2O, py, DMAP, CH2Cl2, 85%
Br CbzHN

HN

Br O OAc O

O O Ph O NO2 Ph

Li, J.; Jeong, S.; Esser, L.; Harran, P. G.; Angew. Chem. Int. Ed. 2001, 40, 4765-4769.

Requirements for PLPGs

A Functionalized Aromatic System Substituents can allow for use of a specic


wavelength radiation

Fast Rate of Cleavage Reduce the time needed for deprotection High quantum yields

Stabilize the radicals or ions created after excitation

Photolabile Protecting Groups (PLPGs)


OR MeO O OMe
Pirrung, M.C.; Bradley, J. C., J. Org. Chem., 1995, 60, 1116-1117.

OMe O MeO O R O R' Ph Ph O

S O

O O

OR

Wang, P.; Wang,Y.; Hu, H.; Spencer, C.; Liang, X.; Pan, L. J. Org. Chem. 2008, 73, 6152-6157.

Kitani. S.; Sugawara, K.; Tsutsumi, K.; Morimoto, T.; Kakiuchi, K.; ChemComm. 2008, 2103-2105.

OR MeO MeO OR NO2 MeO O O

Furuta, T.; Wang, S. S.; Dantzker, J. L.; Dore, T. M.; Bybee, W. J.; Callaway, E. M.; Denk, W.; Tsien, R. Y.; Proc. Natl. Acad. Sci. 1999, 96, 1193-1200.

Requirements for PLPGs

OMe

NO2

!"!# $max (nm) 184 n"!* $max (nm)

217 269

251 299

252 330

Lambert, J. B.; Shurvell, H. F.; Lightner, D. A.; Cooks, R. G.; Organic Structural Spectroscopy, Prentice-Hall: New Jersey,1998, 289.

Requirements for PLPGs

A Functionalized Aromatic System Substituents can allow for use of a specic


wavelength radiation

Fast Rate of Cleavage Reduce the time needed for deprotection High quantum yields

Requirements for PLPGs


Quantum Yield = ! = Number of molecules that undergo cleavage Total number of photons absorbed 0<!<1
OMe OMe Ph Ph O H O Ph

Chlorophyll = 0.25 Rhodopsin = 0.66

MeO O H O Ph

MeO

2 ! = 0.03

3 ! = 0.17

Wang, P.; Wang, J.; Hu, H.; Spencer, C.; Liang, X.; Pan, L. J. Org. Chem. 2008, 73, 6152-6157. Anslyn, E. V.; Dougherty, D. A.; Modern Physical Organic Chemistry; University Science Books: Sausalito, California, 2006, 971.

Dimethoxybenzoin Carbonates
X R4 R3 R2 R1 O

benzene h! (>280nm) Med. P Hg lamp Pyrex Filter


R2 R1 O R3

R4

R1 R2 R3 H H H H H H OMe H OMe
OAc

R4 X Time (hr) Yield H OAc 17 15 H Cl 18 1 H OAc 17 46

MeO O OMe

MeCN h! (360nm) Rayonet reactor pyrex filters 7min, N2


= 0.64

MeO

HOAc
O OMe

99%

Sheenan, J.C.; Wilson, R. M., J. Am. Chem. Soc., 1964, 86, 5277-5281. Sheenan, J. C.; Wilson, R. M.; Oxford, A. W, J. Am. Chem. Soc., 1971, 93, 7222-7228

Dimethoxybenzoin Carbonates
X MeO O OMe

benzene h! (350nm) Rayonet reactor 1h, Ar

MeO

HX
O OMe

OH

SH MeO

OH OH

88%

95%

90%

94%

Pirrung, M.C.; Bradley, J. C., J. Org. Chem., 1995, 60, 1116-1117.

Dimethoxybenzoin Carbonates
OAc MeO O OMe OAc MeO O OMe MeO O OMe MeO OMe OAc

h!

MeO O

HOAc
H OMe O

Boudebous, H.; Ko!mrlj, B.; "ket, B.; Wirz, J., J. Phys. Chem. A., 2007, 111, 2811-2813.

New PLPGs - Thiochromone S,S Dioxide


O

h! (" >280nm) ultra-high P Hg lamp pyrex filter


O O OEt

CD3OD (2.0X10-2M) 0.5h

S >99%

O O

OEt

O O

OR

O O

OR

Kitani, S.; Sugawara, K.; Tsutsumi, K.; Morimoto, T.; Kakiuchi, K. Chem. Comm. 2008, 18, 2103-2105.

New PLPGs - Thiochromone S,S Dioxide

h! (" >280nm) ultra-high P Hg lamp pyrex filter


O O O OEt

S O

CD3OD (2.0X10-2M) 0.5h

EtOH >99%

Kitani, S.; Sugawara, K.; Tsutsumi, K.; Morimoto, T.; Kakiuchi, K. Chem. Comm. 2008, 18, 2103-2105.

New PLPGs - Thiochromone S,S Dioxide


O O

h! (" >280nm)
S O O H O O O O XR

CD3OD
O

S O

O O

XR

CO2
S O O
O

HXR

O O

XR S O O
O

O O

OR

O O

OR

Kitani, S.; Sugawara, K.; Tsutsumi, K.; Morimoto, T.; Kakiuchi, K. Chem. Comm. 2008, 18, 2103-2105.

New PLPGs - Thiochromone S,S Dioxide


O

h! (" >280nm) ultra-high P Hg lamp pyrex filter


O O O O
-2 R CD3OD (2.0X10 M)

ROH
S O O

S O

Alcohol Irradiation Time(h) Yield(%) EtOH C8H17OH


OH OH

Alcohol

Irradiation Time(h) Yield(%) 1.0 >99 (98)

0.5 0.5 0.5 1.0 1.0

>99 >99 >99


Me

OH MeO

1.0
H OMe OAc

>99 (99)

97 98

H HO HO AcO OAc O

OH

0.5

>99 (99)

Kitani, S.; Sugawara, K.; Tsutsumi, K.; Morimoto, T.; Kakiuchi, K. Chem. Comm. 2008, 18, 2103-2105.

New PLPGs - Thiochromone S,S Dioxide


O R' N O

h! (" >280nm) ultra-high P Hg lamp pyrex filter


-2M) CD OD (2.0X10 3 R

O R H N R' O

S O O

S O

Amine C4H9NH2 Et2NH


NH2 CO2Bn

Irradiation Time/h 1.0 1.0 1.0

Yield(%) 97 98 97

Kitani, S.; Sugawara, K.; Tsutsumi, K.; Morimoto, T.; Kakiuchi, K. Chem. Comm. 2008, 18, 2103-2105.

New PLPGs - Thiochromone S,S Dioxide


O

h! (" >280nm) ultra-high P Hg lamp pyrex filter


O O O R

CD3OD (2.0X10-2M)

RCOOH
S O O

S O

RCOOH C11H23COOH C17H35COOH

Irradiation Time/h 1.0 1.0 1.0


COOH

Yield(%) >99 >99 >99

COOH

1.0

>99

Kitani, S.; Sugawara, K.; Tsutsumi, K.; Morimoto, T.; Kakiuchi, K. Chem. Comm. 2008, 18, 2103-2105.

New PLPGs - Ketones and Aldehydes Generation 1


OMe OMe

!MeO O H O H

!-

!-

O O H H Mulliken Charges

O H

O H

S1 -0.193

S0 -0.143

S1 -0.181

S0 -0.159

S1 -0.168

S0 -0.172

Ortho - meta effects on the excited state facilitate


heterolytic cleavage
Zimmerman, H. E.; J. Am. Chem. Soc., 1995, 117, 8988-8991 Wang, P.; Hu, H.; Wang,Y.; Org. Lett., 2007, 9, 2831-2833.

Gaussian 03, Revision C.02 CIS/3-21G for excited states HF/3-21G for geometry optimization

Excited State - Ortho - Meta Effect


MO 7 MO 6

MO 5 MO 4

MO 3 MO 2

MO 1

Zimmerman, H. E., J. Am. Chem. Soc.,1995, 117, 8988-8991.

New PLPGs - Ketones and Aldehydes Generation 1


OMe OMe

!MeO O H O H

!-

!OMe

O O H H Mulliken Charges

O H

O H

MeO

S1 -0.193

S0 -0.143

S1 -0.181

S0 -0.159

S1 -0.168

S0 -0.172

O R1

CH2 O R2

Ortho - meta effects on the excited state facilitate


heterolytic cleavage
Zimmerman, H. E.; J. Am. Chem. Soc., 1995, 117, 8988-8991 Wang, P.; Hu, H.; Wang,Y.; Org. Lett., 2007, 9, 2831-2833.

Gaussian 03, Revision C.02 CIS/3-21G for excited states HF/3-21G for geometry optimization

New PLPGs - Ketones and Aldehydes Generation 1


OMe MeO O H OMe O

h! (>280nm) Med P Hg lamp pyrex sleeve CD3CN/D2O (9:1) 1hr Ph


H

O Ph

50%

h! (>280nm) Med P Hg lamp pyrex sleeve


O H O

O H Ph

CD3CN/D2O (9:1) 1hr Ph h! (>280nm) Med P Hg lamp pyrex sleeve

8%

Ph O O CD3CN/D2O (9:1) H 1hr H Ph Wang, P.; Hu, H.; Wang,Y.; Org. Lett., 2007, 9, 2831-2833.

New PLPGs - Ketones and Aldehydes Generation 1


OMe O R1 R2 10 mol%, p-TsOH MeO OH OH OMe

h! (>280nm) Med. P Hg lamp pyrex filter MeCN/H2O (4:1)


CHO

MeO O R1 O R2

O O

Ph

CHO OPh MeO

16

Protection Yield: Deprotection Yield: Time (h):

92 81 4.0

99 79 0.5

93 86 3.0

91 93 3.5

Wang, P.; Hu, H.; Wang,Y.; Org. Lett., 2007, 9, 2831-2833.

New PLPGs - Ketones and Aldehydes Generation 2


O

OMe Ph O R1 O R2

OMe Ph

OMe Ph O R1 O R2

R1 R2 10 mol%, p-TsOH Ph

Ph

Ph
OH

OH

h! (>280nm) Med. P Hg lamp pyrex filter MeCN


CHO

O Ph CHO
8

OMe

MeO

Protection Yield: Deprotection Yield: Time (min):

99 90 60

99 89 60

91 86 60

93 84 80

Wang, P.; Hu, H.; Wang,Y.; Org. Lett., 2007, 9, 1533-1535.

New PLPGs - Ketones and Aldehydes Optimized System


OMe OMe Ph Ph OH 1 OH OH OH OMe Ph Ph OH OH

MeO

MeO

PPG 1 2 3

! 0.03 0.11 0.17

protection yield (%) deprotection yield (%) time (min) 92 99 99 81 90 92 240 60 30

Wang, P.; Wang, J.; Hu, H.; Spencer, C.; Liang, X.; Pan, L. J. Org. Chem. 2008, 73, 6152-6157.

New PLPGs - Ketones and Aldehydes Optimized System


O OMe Ph MeO OH R1 R2 10 mol%, p-TsOH Ph OMe Ph O R1 O R2 O O OPh MeO
16

OH

h! (>280nm) Med. P Hg lamp MeO pyrex filter MeCN/H2O 10%(v/v)


CHO

Ph

Ph

CHO

Protection Yield: Deprotection Yield: Time (h):

99 92 30

93 82 44

99 88 25

99 91 25

Wang, P.; Wang, J.; Hu, H.; Spencer, C.; Liang, X.; Pan, L. J. Org. Chem. 2008, 73, 6152-6157.

New PLPGs - Ketones and Aldehydes Optimized System


OMe Ph Ph O R2 OMe OMe Ph MeO O R1 O R2 R1 OMe Ph O R2

MeO O R1

h!

H2O
MeO O Ph Ph

h! -H2O

MeO OH

Ph Ph OH

Wang, P.; Wang, J.; Hu, H.; Spencer, C.; Liang, X.; Pan, L. J. Org. Chem. 2008, 73, 6152-6157.

New PLPGs - Ketones and Aldehydes Optimized System


Reagent PhLi LiAlH4 Solvent THF THF THF THF MeCN MeCN MeCN MeCN MeCN MeCN MeCN Conditions -78 to 23C, 6h 23C, 24h 23C, 24h 23C, 18h 23C, 24h 80C, 2h 23C, 24h 80C, 2h 23C, 24h 80C, 2h 23C, 24h 80C, 2h 23C, 24h 80C, 2h 23C, 24h 80C, 2h 23C, 24h 80C, 2h %Recovery 100 100 100 100 100 100 100 94 0 0 100 100 100 91 100 65 47 0 NaBH4 H2, Pd/C

OMe Ph Ph O H O Ph

t-BuOK DDQ CAN AcOH TFA HCl (37%) pTsOH

MeO

Wang, P.; Wang, J.; Hu, H.; Spencer, C.; Liang, X.; Pan, L. J. Org. Chem. 2008, 73, 6152-6157.

New PLPGs - Ketones and Aldehydes Amino Acetal


R1

h# (>280nm)
R2 O H O

O H Ph

Med. P Hg lamp pyrex filter Ph Yield 99 92 Time 16 30

R1 N(Me)2 OMe

R2 H OMe

! 0.13 0.17

"max 327 297

Wang, P.; Wang, J.; Hu, H.; Spencer, C.; Liang, X.; Pan, L. J. Org. Chem. 2008, 73, 6152-6157.

Orthogonality Using PLPGs

OMe Ph Ph O H O Ph

N Ph Ph O H O Ph

OMe

MeO

h! MeCN/ MeO H2O (1:1)

O Ph Ph O H O Ph H Ph

350nm, 20min: 98% sunlight, 3h : 98%

>89% >96%

Wang, P.; Wang, J.; Hu, H.; Spencer, C.; Liang, X.; Pan, L. J. Org. Chem. 2008, 73, 6152-6157.

Orthogonality Using PLPGs


O O S O O O O O O O O O O O O S O

h! (" >280nm) CD3OD, 0.5h 99%

OH O

CO2
S O

Kitani, S.; Sugawara, K.; Tsutsumi, K.; Morimoto, T.; Kakiuchi, K. Chem. Comm. 2008, 18, 2103-2105.

Orthogonality Using PLPGs


O O

mCPBA 85%
S O O O OH O S O O O O O OH

h! (" >280nm) CD3OD, 0.5h 99%

HO

OH S O O 85%

CO2

>99%

Kitani, S.; Sugawara, K.; Tsutsumi, K.; Morimoto, T.; Kakiuchi, K. Chem. Comm. 2008, 18, 2103-2105.

Orthogonality Using PLPGs


OMe O2N MeO O O O
n

OMe OMe

O O

n 254 nm 420 nm (%) (%) 0 420 nm 1 2 OMe 3 4 5


O O O

254 nm

h!, then CH2N2

O2N MeO O
n

OMe OMe

86 94 94 96 78 92
n

67 83 85 85 87 70
OMe O

O O

MeO

Blanc, A.; Bochet, C. G., J. Org. Chem., 2002, 67, 5567-5577.

o-Nitrobenzyl is most widely used and has been


applied to total syntheses
NO2 H O R O R'

Summary of Uses of PLPGs in Synthesis

Thiochromone systems could be an alternative


although optimization required
O S O O O O O R

Acetal protection system for aldehydes and ketones


is groundbreaking
OMe MeO O R1

Proof of orthogonality makes PLPG more practical

Ph Ph O R2

Caged Biomolecules

PLPG inactivates the biomolecule until irradiated Biomolecules that have been caged include: neurotransmitters, ATP, P , Glutamate An effective method to elucidate cellular functions of
i

biomolecules

Release occurs on a biologically relevant time scale as


compared to diffusion (temporal resolution) resolution)

Release can be controlled to a specic area (spacial


Furuta, T.; Wang, S. S.; Dantzker, J. L.; Dore, T. M.; Bybee, W. J.; Callaway, E. M.; Denk, W.; Tsien, R.Y.; Proc. Natl. Acad. Sci. 1999, 96, 1193-1200.

Caged Biomolecules - C. Elegans

Li, H.; Avery, L.; Denk, W.; Hess, G. P., Proc. Natl. Acad. Sci. USA, 1997, 94, 5912-5916.

Caged Biomolecules - C. Elegans


NO2 O COO-O NH3+ COO-

h!

NO O COOHO O

NH3+ COO-

Li, H.; Avery, L.; Denk, W.; Hess, G. P., Proc. Natl. Acad. Sci. USA, 1997, 94, 5912-5916.

Light Triggered Molecule-Scale Dosing


OCH3 O OCH3 O O O O O O O O OCH3 O O OCH3 O OCH3 OCH3

Acetylsalicylic acid

Ibuprofen

Ketoprofen

McCoy, C. P.; Rooney, C.; Edwards, C. R.; Jones, D. S.; Gorman, S. P.; J. Am. Chem. Soc. 2007, 129, 9572-9573.

Light Triggered Molecule-Scale Dosing


90 Yield of Ibuprofen (%) 60 Off 30 Off 0 0 Off On 10
OCH3 O OCH3 O O

Off Off On On

Off On On

On

20 Time (min)

30
O OCH3 O OCH3 HO

40

h! (365 nm) Hg lamp quartz cuvette

Ibuprofen

McCoy, C. P.; Rooney, C.; Edwards, C. R.; Jones, D. S.; Gorman, S. P.; J. Am. Chem. Soc. 2007, 129, 9572-9573.

Taxol Prodrug
O O OH O O O O HO O H O O O N H O OH HO O O H O O O O

O O H2N O

O O OH

Taxol 2.5 x 10-4 mg/mL Isotaxel 0.45 mg/mL

Skwarczynski, M.; Sohma, Y.; Noguchi, M.; Kimura, M.; Hayashi,Y.; Hamada,Y.; Kiso,Y.; Kimura, T.; J. Med. Chem. 2005, 48, 2655-2666.

Taxol Prodrug
N HCl O O

O O NH O O O

O O OH O O

O O OH

430 nm diode laser


H2N O O O HO O H O O O

HO O

H O

O O

Phototaxel < 2.5 x 10-4 mg/mL

Isotaxel 0.45 mg/mL

Skwarczynski, M.; Noguchi, M.; Hirota, S.; Sohma, Y.; Kimura, T.; Hayashi,Y.; Kiso,Y.; Bioorg. Med. Chem. Lett. 2006, 16, 4492-4496.

Taxol Prodrug
100

N HCl

80

2
O O NH O O O O

O O OH

60

(%)

O HO O H O O O

40

20

0 0 5 10 15 Time (min) 20 25 30

1
O O N H O OH

O O OH

OH

=1 =2 =5

O HO O H O O O

Skwarczynski, M.; Noguchi, M.; Hirota, S.; Sohma, Y.; Kimura, T.; Hayashi,Y.; Kiso,Y.; Bioorg. Med. Chem. Lett. 2006, 16, 4492-4496.

Taxol Prodrug
O

3 HCl
O

N NH

N H

N O O O O OH

O N O NH O O O

O O OH

O O

365 nm
H O O UV lamp O O

H2N O

O O

O HO O H O O O

HO O

Phototaxel 2 > 100mg/mL

Isotaxel 0.45 mg/mL

Skwarczynski, M.; Noguchi, M.; Hirota, S.; Sohma, Y.; Kimura, T.; Hayashi,Y.; Kiso,Y.; Bioorg. Med. Chem. 2008, 16, 5389-5397.

O O N H O O OH HO O O

O O OH

Taxol Prodrug
100

O H O O
(%)

80

Taxol
O

60

40

3 HCl
O

N NH

N H

N O O
20

O N O NH O O O

O O OH

0 0 10 20 30 Time (min) 40 50 60

O HO O H O O O

= Taxol = Phototaxel

Phototaxel

Skwarczynski, M.; Noguchi, M.; Hirota, S.; Sohma, Y.; Kimura, T.; Hayashi,Y.; Kiso,Y.; Bioorg. Med. Chem. 2008, 16, 5389-5397.

UV Damage
100 150 200 250 300 350 Wavelength 400 (nm)

X-Rays

Ultraviolet radiation UVC UVB UVA

Visible light

Preceding PLPGs required 280 - 365nm radiation for


cleavage
Matsumura, Y.; Ananthaswamy, H. N.; Toxicol. Appl. Pharmacol. 2004, 195, 298-308.

UV Damage
Sunburn, Suntan, Epidermal Hyperplasia DNA damage
Acute UV

Cell cycle control Apoptosis

DNA Repair

p53 induction

Maintenance of genomic stability DNA replication and repair Immune Suppression Angiogenesis inhibition

Skin aging (Photoaging)

Chronic UV

DNA damage accumulation

Genetic mutations

Immune suppression

Skin carcinogenesis

Matsumura, Y.; Ananthaswamy, H. N.; Toxicol. Appl. Pharmacol. 2004, 195, 298-308.

Two Photon Excitation

Maria Gppert-Mayer rst described non-linear


optics - 1931

Theodore Maiman developed the ruby laser -1960 W. Kaiser and C. B. G. Garrett observed two photon
excited uorescence in CaF2:Eu2+ crystals- 1961 microscopy - 1980s

Janis Valdemanis and R. L. Fork described multiphoton D. E. Spence, P. N. Kean and W. Sibbert developed Tisapphire femtosecond laser - 1990
Masters, B.R.; So, P. T. C., Microscopy Research and Technique, 2004, 63, 3-11.

Two Photon Excitation


S2 IC S1
Fluorescence

S2 IC ISC T1
Phosphorescence
Fluorescence

S1

ISC T1 Excitation Virtual State


Phosphorescence

S0

Excitation

S0

UV One Photon Excitation

IR Two Photon Excitation

Oheim, M.; Michael, D. J.; Geisbauer, M.; Madsen, D.; Chow, R. H.; Adv. Drug Deliv. Rev., 2006, 58, 788808

Two Photon Excitation

Utilizes IR radiation instead of UV Requires concentrated photons and provides increased


spacial and temporal control of excitation

Not sensitive to scattering No out-of-focus absorption Photobleaching and photodamage is limited to the
location of excitation

Increases Depth Penetration


Piston, D. W.; Adv. Drug Deliv. Rev., 2006, 58, 770-772.

One Photon UV

Two Photon Excitation

Two Photon IR

Caged Biomolecule

Released Biomolecule

PLPG

Furuta, T.; Wang, S. S.; Dantzker, J. L.; Dore, T. M.; Bybee, W. J.; Callaway, E. M.; Denk, W.; Tsien, R. Y.; Proc. Natl. Acad. Sci. 1999, 96, 1193-1200.

Two Photon Excitation

Oheim, M.; Michael, D. J.; Geisbauer, M.; Madsen, D.; Chow, R. H.; Adv. Drug Deliv. Rev., 2006, 58, 788808.

Two Photon Excitation

Oheim, M.; Michael, D. J.; Geisbauer, M.; Madsen, D.; Chow, R. H.; Adv. Drug Deliv. Rev., 2006, 58, 788808.

Two Photon Excitation

Utilizes IR radiation instead of UV Requires concentrated photons and provides increased


spacial and temporal control of excitation

Not sensitive to scattering No out-of-focus absorption Photobleaching and photodamage is limited to the
location of excitation

Increases Depth Penetration


Piston, D. W.; Adv. Drug Deliv. Rev., 2006, 58, 770-772.

Two Photon Excitation


One Photon UV Two Photon IR

Denk, W.; Helmchen, F.; Nature Methods, 2005, 12, 932-940.

Two Photon Excitation

Utilizes IR radiation instead of UV Requires concentrated photons and provides increased


spacial and temporal control of excitation

Not sensitive to scattering No out-of-focus absorption Photobleaching and photodamage is limited to the
location of excitation

Increases Depth Penetration


Piston, D. W.; Adv. Drug Deliv. Rev., 2006, 58, 770-772.

Two Photon Excitation

Confocal microscopy depth in


brain tissue: 50 - 100!m the brain tissue

Used for imaging of slices of Two Photon Excitation depth in


brain tissue: up to 1mm deeper in a tumor

Could lead to excitation


Denk, W.; Helmchen, F.; Nature Methods, 2005, 12, 932-940.

Coumarin Derivatives
O CH2OP(OC2H5)2 CH2Nu

h! (360nm)
H3CO O O

Nu

H3CO

Nu = CH3OH, piperidine, cysteine, tyrosine, "-chymotrypsin NH2


N O P O O O O N O N N NH2 N O P O O O HO N O N N

Dioxane/Water (1:1) h! (340nm) Xe lamp 1h, Ar, 90%

H3CO

cAMP

Givens, R. S.; Matuszewski, B., J. Am. Chem. Soc., 1984, 106, 6860-6861. Furuta, T.; Toriagai, H.; Sugimoto, M.; Iwamura, M., J. Org. Chem., 1995, 60, 3953-3956.

Coumarin Derivatives
O MeO MeO O NO2 NH3 CO2 HO O O OAc Cl O O O OAc

1 !-DMNB-glu Cmpd 1 2 3 "(365nm) 0.006 0.025 0.01

2 !u(740nm (GM))

3 !u(800nm (GM))

1.07 0.05 1.07 0.07

0.13 0.001 0.34 0.02

Furuta, T.; Wang, S. S.; Dantzker, J. L.; Dore, T. M.; Bybee, W. J.; Callaway, E. M.; Denk, W.; Tsien, R.Y.; Proc. Natl. Acad. Sci. 1999, 96, 1193-1200.

Cross Sectional Area of Uncaging ("u)

Measures the efciency of the chromophore to


absorb two photons

Dependent on: Cross-sectional area of the chromophore


1"u = 10-50 cm4s/photon = 1GM
Albota, M., et. al.; Science, 1998, 281, 1653-1656.

Coumarin Derivatives
O MeO MeO O NO2 NH3 CO2 HO O O OAc Cl O O O OAc

1 !-DMNB-glu Cmpd 1 2 3 "(365nm) 0.006 0.025 0.01

2 !u(740nm (GM))

3 !u(800nm (GM))

1.07 0.05 1.07 0.07

0.13 0.001 0.34 0.02

Furuta, T.; Wang, S. S.; Dantzker, J. L.; Dore, T. M.; Bybee, W. J.; Callaway, E. M.; Denk, W.; Tsien, R.Y.; Proc. Natl. Acad. Sci. 1999, 96, 1193-1200.

Coumarin Derivatives
OAc Br O O O Br O Br 5 O OAc Br O

NH3 CO2 Br O

O Br O O O O 6

O O O

H N CO2

CO2

O 7 Bhc-glu

Cmpd 4 5 6 7

!(365nm) 0.037 0.065 0.019 0.019

!u(740nm (GM)) 1.99 0.09 0.96 0.05 0.89 0.24 0.95 0.21

!u(800nm (GM)) 0.42 0.01 3.1 0.2 0.42 0.11 0.37 0.06

Furuta, T.; Wang, S. S.; Dantzker, J. L.; Dore, T. M.; Bybee, W. J.; Callaway, E. M.; Denk, W.; Tsien, R.Y.; Proc. Natl. Acad. Sci. 1999, 96, 1193-1200.

Coumarin Derivatives
100 80

60
(%)

40

!= 1 "!7

20

0 0 10 20 30 Time (min) 40 50 60

O MeO MeO O NO2 NH3 CO2 Br O O

O O O

H N CO2

CO2

1 !-DMNB-glu 7 Bhc-glu Furuta, T.; Wang, S. S.; Dantzker, J. L.; Dore, T. M.; Bybee, W. J.; Callaway, E. M.; Denk, W.; Tsien, R.Y.; Proc. Natl. Acad. Sci. 1999, 96, 1193-1200.

Coumarin Derivatives - Mechanism of Cleavage


OR H C H OR

333nm
H3CO CH2 O O H3CO O O

SET

CH2OH

OR
H3CO O O

H2O
H3CO O O

HOR

Schmidt, R.; Geisser, D.; Hagen,V.; Bendig, J., J. Phys. Chem. A., 2007, 111, 5768-5774.

Conclusions

Usage is an attractive alternative to classical protecting


groups

Technique is still in its infancy and further optimization


is required before wide spread usage systems tumors

Has the potential to revolutionize drug delivery Combined application with ber optics to target

Acknowledgements

Dr. Babak Borhan Dr. Ned Jackson Dr. Petr Klan Toyin, Aman, Arvind, Camille, Dan, Calvin, Xiaoyong, All of you for your attention

Mercy, Roozbeh, Atefeh, Sarah, Sing, Wenjing, Xiaofei, Chryssoula

You might also like